MAZE logo
MAZE

Maze Therapeutics Inc

Pharmaceuticals

Maze Therapeutics Inc (MAZE) Earnings

Last reported
May 20, 2026
EPS estimate
-$0.56
EPS actual
Revenue est.
$9.5M
Revenue actual